Immediate-Release 5-HT6 Antagonist Tablets for Rapid Drug Release

The formulation divides the pharmaceutical composition into distinct functional segments: binders (5-15% w/w) for tablet integrity, disintegrants (5-15% w/w) for rapid breakdown, lubricants (0.5-2% w/w) for manufacturing, and glidants (0.5-2% w/w) for flow. This segmentation allows each component to perform its specific function optimally, achieving rapid drug release while maintaining manageable formulation complexity through standardized ingredient categories.

The diluent serves multiple functions simultaneously: it provides bulk to the formulation, acts as a filler to achieve desired tablet weight, contributes to tablet hardness, and facilitates drug release. This multi-functionality reduces the number of separate ingredients needed, simplifying the overall formulation while maintaining rapid release characteristics.

The formulation specifies weight ratio ranges rather than fixed values: binders (5-15% w/w), disintegrants (5-15% w/w), lubricants (0.5-2% w/w), and glidants (0.5-2% w/w). This parameter approach allows manufacturing flexibility while ensuring rapid drug release, as long as the ratios fall within the specified ranges. The disintegrant-to-binder ratio of 1:1 to 3:1 is particularly critical for achieving release within 30 minutes.

The formulation uses sufficient quantities of disintegrants (5-15% w/w) to ensure complete tablet breakdown and rapid drug release within 30 minutes. This excessive action of disintegration guarantees that even with variations in manufacturing precision, the drug release target is consistently met. The lubricant amount (0.5-2% w/w) is kept minimal to avoid interfering with disintegration while still preventing sticking during compression.

The binder is applied preliminarily during granulation or directly during compression to provide initial structural framework for tablet formation. This preliminary binding action ensures the tablet maintains its shape during handling and storage, while the subsequently added disintegrant (in 5-15% w/w ratio) ensures rapid breakdown upon contact with gastric fluid, achieving both stability and rapid absorption.

The formulation creates local quality differences between the tablet exterior and interior. The binder concentration (5-15% w/w) provides structural stability throughout the tablet matrix, while the disintegrant (5-15% w/w) is distributed to create localized zones of rapid breakdown. The lubricant (0.5-2% w/w) is applied as a surface coating to prevent sticking without interfering with internal disintegration, allowing the tablet to maintain integrity during compression but rapidly disintegrate during dissolution.